Holen Sie sich die Stockscreener-App
3.88
0.52%
0.02
Schlusskurs vom Vortag:
$3.86
Offen:
$3.9
24-Stunden-Volumen:
80,738
Relative Volume:
1.80
Marktkapitalisierung:
$29.00M
Einnahmen:
$7.00M
Nettoeinkommen (Verlust:
$-70.79M
KGV:
-0.4004
EPS:
-9.69
Netto-Cashflow:
$-64.34M
1W Leistung:
-0.51%
1M Leistung:
-10.80%
6M Leistung:
-38.41%
1J Leistung:
-36.57%
1-Tages-Spanne:
$3.85
$3.94
1-Wochen-Bereich:
$3.85
$4.0699
52-Wochen-Spanne:
$3.6201
$9.18
Kezar Life Sciences Inc Stock (KZR) Company Profile
Firmenname
Kezar Life Sciences Inc
Sektor
Branche
Telefon
650-822-5600
Adresse
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie KZR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
3.88 | 29.00M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.76 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.28 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.78 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
656.89 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.51 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2018-07-16 | Eingeleitet | Jefferies | Buy |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
| 2018-07-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Kezar Life Sciences Inc Aktie (KZR) Neueste Nachrichten
Smart tools for monitoring Kezar Life Sciences Inc.’s price actionPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Live market analysis of Kezar Life Sciences Inc.Gap Down & Stepwise Trade Signal Implementation - Newser
Should you wait for a breakout in Kezar Life Sciences Inc.Market Activity Recap & Long-Term Growth Portfolio Plans - Newser
What the charts say about Kezar Life Sciences Inc. todayTrade Risk Summary & Detailed Earnings Play Alerts - Newser
What does recent volatility data suggest for Kezar Life Sciences Inc.2025 Winners & Losers & Detailed Earnings Play Strategies - Newser
Short interest data insights for Kezar Life Sciences Inc.July 2025 Snapshot & Stock Portfolio Risk Control - Newser
Forecasting Kezar Life Sciences Inc. price range with options data2025 Performance Recap & AI Driven Stock Reports - Newser
Is this a good reentry point in Kezar Life Sciences Inc.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
What to do if you’re stuck in Kezar Life Sciences Inc.Earnings Overview Report & Real-Time Buy Zone Alerts - Newser
What earnings revisions data tells us about Kezar Life Sciences Inc.Quarterly Risk Review & Weekly Top Gainers Trade List - Newser
Is Kezar Life Sciences Inc. stock entering bullish territoryPortfolio Performance Report & Long-Term Investment Growth Plans - Newser
William Blair Brokers Boost Earnings Estimates for KZR - Defense World
Real time social sentiment graph for Kezar Life Sciences Inc.Quarterly Trade Report & Smart Swing Trading Techniques - Newser
Is Kezar Life Sciences Inc. stock reversal real or fakeQuarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Technical Bounce Expected in Kezar Life Sciences Inc. Next WeekMarket Performance Report & High Win Rate Trade Alerts - classian.co.kr
Main Inc. stock outlook for YEARJuly 2025 Volume & Comprehensive Market Scan Reports - Newser
What candlestick patterns are forming on Kezar Life Sciences Inc.July 2025 Levels & AI Based Buy and Sell Signals - Newser
How Kezar Life Sciences Inc. stock reacts to Fed policy changesTrade Performance Summary & Safe Swing Trade Setups - Newser
Is Kezar Life Sciences Inc. likely to announce a buybackJuly 2025 Big Picture & Fast Exit and Entry Strategy Plans - thegnnews.com
Kezar Life Sciences Inc. Recovery Likely Here’s What Data ShowsValue Driven Trading Forecast Strategy - beatles.ru
Wells Fargo Keeps Their Hold Rating on Kezar Life Sciences (KZR) - The Globe and Mail
Is it too late to sell Kezar Life Sciences Inc.Trend Reversal & Stepwise Trade Execution Plans - Newser
Should you hold or exit Kezar Life Sciences Inc. nowQuarterly Portfolio Report & Breakout Confirmation Trade Signals - Newser
How to escape a deep drawdown in SoundHound AI Inc. Equity WarrantWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - Newser
Should you hold or exit Sprouts Farmers Market Inc. nowJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Using AI based signals to follow Arrowhead Pharmaceuticals Inc.Weekly Trading Summary & Fast Gaining Stock Reports - Newser
Detecting support and resistance levels for Kezar Life Sciences Inc.July 2025 Big Picture & High Return Stock Watch Alerts - Newser
Can technical indicators confirm Kezar Life Sciences Inc.’s reversalWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
How to use a screener to detect Kezar Life Sciences Inc. breakoutsJuly 2025 Patterns & Stock Market Timing Techniques - Newser
How Kezar Life Sciences Inc. stock performs during market volatilityMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Can Kezar Life Sciences Inc. ride the EV wave2025 Market Overview & High Accuracy Investment Entry Signals - sundaytimes.kr
Kezar Life Sciences' Positive Trial Results and Regulatory Progress Boost Buy Rating - AInvest
Positive Phase 2 Trial Results and Regulatory Progress Bolster Buy Rating for Kezar Life Sciences - TipRanks
Kezar Life Sciences Advances in Autoimmune Hepatitis Trials - TipRanks
Why Kezar Life Sciences Inc. stock attracts strong analyst attentionCEO Change & AI Driven Price Predictions - Newser
Published on: 2025-08-16 23:04:27 - Newser
Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kezar Life Sciences Inc-Aktie (KZR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schiller Mark C. | Chief Operating Officer |
Jul 02 '25 |
Sale |
4.28 |
561 |
2,401 |
2,739 |
0.22%
3.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):